Student Changes Life Plans to Help Others with MS
Just like any student, Stephanie Butler was excited to start working, in her case as a nurse, when she began experiencing…
Articles by Patricia Silva, PhD
MediciNova Completes Enrollment for Phase 2b Study of Experimental Progressive Multiple Sclerosis Treatment
MediciNova, Inc., a publicly-traded biopharmaceutical company developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs,…
Innate Immunotherapeutics Joins MS Consortium
US-based Multiple Sclerosis Outcome Assessments Consortium (MSOAC) has invited New Zealand-based Innate Immunotherapeutics Limited to join their efforts to develop clinical…
FDA Evaluates ZINBRYTA For MS Treatment
The U.S. Food and Drug Administration (FDA) has announced it will consider marketing approval of ZINBRYTA (daclizumab high-yield process),…
MSAA Publishes 2015 MS Research Updates for Multiple Sclerosis Management
The Multiple Sclerosis Association of America (MSAA) recently published the latest MS Research…
Promising New Therapy for Multiple Sclerosis Based on Placenta Cells
A study published in the journal Multiple Sclerosis and Related Disorders, led by researchers at Mount…
MS Society To Invest £2 million in Edinburgh Centre for Multiple Sclerosis Research
The MS Society recently announced it will invest £2 million into the Edinburgh Centre for MS Research. This funding will support the…
MS Views and News to Host Educational Patient Programs in May
MS Views and News (MSVN), a non-profit organization focused on collecting and distributing information about multiple sclerosis (MS),…
Researchers, Biotech Companies Present Key MS Discoveries & Therapy Updates at Recent Conference
The 67th American Academy of Neurology Annual Meeting took place last week in Washington, DC and included eight investigators…
FDA Accepts Bayer’s BETACONNECT License Application for Relapsing-Remitting Multiple Sclerosis
Bayer HealthCare recently announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of a supplemental…
Study Tests Safety & Efficacy of New Treatment Intervals For MS Therapy Natalizumab
A new study presented last week during the American Academy of Neurology’s 67th Annual Meeting in Washington, DC provides new…
Actelion to Accelerate Clinical Trials For Experimental Therapy That Treats MS, Other Autoimmune Diseases
Actelion Pharma recently announced that it will accelerate the launch of clinical trials involving its lead drug candidate ponesimod, an oral, selective…
NYU Langone Researchers Report What Happens When Multiple Sclerosis Patients Abandon Treatment
A team led by researchers at the New York University (NYU) Langone Medical Center recently assessed what happens when clinically…
MS Experts Join New Medical Advisory Board at MS Views & News
The non-profit organization MS Views and News (MSVN) has invited two health care experts on…
Biogen To Present Data On The Effectiveness of TECFIDERA In Newly-Diagnosed MS Patients During The ANN Annual Meeting
Biogen has recently announced novel results to support the effectiveness of TECFIDERA (dimethyl fumarate) in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS).
Epilepsy Drug May Treat Eye Complications in Patients With MS
A new study to be presented during the American Academy of Neurology’s 67th Annual Meeting, April 24, in Washington, DC, explores…
Genetic Variants Found to Play a Role in Antibody Production and Disease Severity in Multiple Sclerosis Patients
Dr. Jose Álvarez-Cermeño and Dr. Luisa Villar from Instituto Ramón y Cajal de Investigación Sanitaria in Madrid, Spain recently published…
First Generic Version of Copaxone Approved by FDA to Treat Multiple Sclerosis
The U.S. Food and Drug Administration (FDA) has announced the approval of the first generic version…
Experimental Drug Appears to Repair Nerve Damage in Multiple Sclerosis Patients
The American Academy of Neurology (AAN) recently announced the results of a new study that evaluated an experimental drug for…
Beta-Interferon Therapy Has No Effect on Secondary Progressive MS Onset According to Study
A team led by researchers at the University of British Columbia in Canada recently published results in the…
Modified Story Memory Technique (mSMT) Might be Affected by Cognitive Dysfunction in Patients with Multiple Sclerosis
A team of Kessler Foundation researchers recently published their findings on the MEMREHAB trial, whereby treatment with the modified…
New Novartis Analyses On Gilenya For Relapsing Multiple Sclerosis To Be Presented at Upcoming Conference
Novartis will present novel Gilenya data, demonstrating the company’s methods for assessing the impact of relapsing multiple sclerosis (RMS) in both patients and physicians,…
MedDay To Release Phase III Clinical Trial Results for Experimental Progressive Multiple Sclerosis Therapy
MedDay recently announced in a news release that it is preparing to release the design and results of its…
MS Patient Travels Abroad to Receive Stem Cell Treatment
A stem cell therapy being administered to treat multiple sclerosis (MS) outside the United States was recently…
National MS Society Announces $28 Million Funding For Research
The National Multiple Sclerosis Society has announced it will grant $28 million to 84 new research projects and training…
Consortium of MS Centers Launches Mentorship Program
The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC) is launching a new mentorship program dedicated to medical residents…
Central Immune System Component Found to be Related to MS Neurodegeneration, Clinical Disability
A recent study published in PLOS ONE provides new insights into the relationship between the immune system and neurodegeneration…
Vaccinex Releases Pre-clinical Data on Experimental Multiple Sclerosis Therapy
Vaccinex, Inc. recently announced positive results for a multi center, randomized, double-blinded, placebo-controlled phase 1 clinical trial that evaluated single…
Statins Therapy in Multiple Sclerosis Yields Controversial Results
Researchers at the IRCCS Centro Neurolesi “Bonino-Pulejo” and the University of Messina in Italy have performed a review…
MS Research Australia Funds Project on MS and Epstein-Barr Virus
MS Research Australia has awarded a $150,000 grant to support a project being conducted at Murdoch University aimed at expanding scientific knowledge on the…